Fenofex 300mg. 20mg / 1ml FC tablet
PDF Leaflet Revision Date: 08 August 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of symptoms associated with SAR and CIU.
Dosage (summary)
Adults: 120 mg for SAR, 180 mg for CIU daily. Renal impairment: 60 mg once daily.
Onset of Action / Duration
Onset: 1 hour, Duration: 24 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established for pregnancy or breastfeeding; avoid use.
Key Drug Interactions
- Erythromycin
- Ketoconazole
- Antacids containing aluminium and magnesium
Contraindications
- Hypersensitivity to fexofenadine
- Pregnancy
- Lactation
- Children under 12
Common side effects
- Headache
- Drowsiness
- Dizziness
- Nausea
Counselling Points
- Avoid alcohol and CNS depressants
- Monitor for sedation
- Report any adverse reactions
Serious warnings
- Adverse reactions in cardiovascular disease
- May affect ability to drive
Important Disclaimer
The Fenofex 300mg. 20mg / 1ml FC tablet professional information leaflet below is the property of Ranbaxy Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
